Singapore approves Gilead's remdesivir for COVID-19 treatment
2:01am PDT - June 10th, 2020 remdesivir - ReutersSingapore's Health Sciences Authority said on Wednesday it granted conditional approval for Gilead Sciences Inc's antiviral drug remdesivir for the treatment of some patients with COVID-19 infection.